ALS along the Axons - Expression of coding and noncoding RNA differs in axons of ALS models

Nimrod Rotem, Iddo Magen, Ariel Ionescu, Noga Gershoni-Emek, Topaz Altman, Christopher J. Costa, Tal Gradus, Metsada Pasmanik-Chor, Dianna E. Willis, Iddo Z. Ben-Dov, Eran Hornstein, Eran Perlson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Amyotrophic lateral sclerosis (ALS) is a multifactorial lethal motor neuron disease with no known treatment. Although the basic mechanism of its degenerative pathogenesis remains poorly understood, a subcellular spatial alteration in RNA metabolism is thought to play a key role. The nature of these RNAs remains elusive, and a comprehensive characterization of the axonal RNAs involved in maintaining neuronal health has yet to be described. Here, using cultured spinal cord (SC) neurons grown using a compartmented platform followed by next-generation sequencing (NGS) technology, we find that RNA expression differs between the somatic and axonal compartments of the neuron, for both mRNA and microRNA (miRNA). Further, the introduction of SOD1 G93A and TDP43 A315T, established ALS-related mutations, changed the subcellular expression and localization of RNAs within the neurons, showing a spatial specificity to either the soma or the axon. Altogether, we provide here the first combined inclusive profile of mRNA and miRNA expression in two ALS models at the subcellular level. These data provide an important resource for studies on the roles of local protein synthesis and axon degeneration in ALS and can serve as a possible target pool for ALS treatment.

Original languageEnglish
Article number44500
JournalScientific Reports
Volume7
DOIs
StatePublished - 16 Mar 2017

Fingerprint

Dive into the research topics of 'ALS along the Axons - Expression of coding and noncoding RNA differs in axons of ALS models'. Together they form a unique fingerprint.

Cite this